Mercado de los dispositivos de biopsia en México

Overview of the Biopsy Devices Market in Mexico:

The biopsy device market in Mexico reached USD 44.3 million in 2025. Looking ahead, IMARC Group expects the market to reach USD 70.1 million by 2034 , exhibiting a compound annual growth rate (CAGR) of 5.07% during 2026-2034 .  The market is experiencing significant growth due to the increasing prevalence of cancer, growing health awareness among the population, which encourages them to opt for accurate and early diagnosis, and greater access to advanced healthcare. Furthermore, technological innovation in minimally invasive tools and increased public and private investment in early detection services are other important factors driving growth and increasing the market share of biopsy devices in Mexico.

Trends in the biopsy device market in Mexico:

Increased incidence of cancer

The rising prevalence of cancer in Mexico is significantly influencing the demand for accurate, early-stage diagnostic tools. This trend is a key driver of growth in the Mexican biopsy device market, with an increase in biopsy procedures in both public hospitals and private diagnostic centers. Breast, cervical, prostate, and lung cancers are among the most frequently diagnosed, generating a sustained need for core needle, fine needle, and vacuum-assisted biopsy tools. According to a report published by the OECD, cancer remains a major public health problem in Mexico, causing one in 14 premature deaths. By 2050, it is estimated that there will be 46,200 premature cancer deaths annually, reducing life expectancy by 0.9 years. Healthcare spending will increase by 10.6 billion pesos annually, and cancer will reduce labor productivity by 138,000 jobs. Early detection campaigns and awareness programs have also led to more frequent screening, especially in urban areas. As access to healthcare expands and more people seek preventative diagnoses, biopsy devices are becoming essential in routine clinical workflows. The rising incidence of cancer has prompted public and private institutions to invest in modern diagnostic infrastructure, further expanding the use of biopsy equipment and strengthening the market share of biopsy devices in Mexico across all oncology-focused healthcare services.

Greater awareness and early detection

Increased health education efforts across Mexico are encouraging more people to participate in routine cancer screenings, particularly for breast and cervical cancer. Healthcare professionals are playing a key role by actively referring patients for early diagnostic evaluations. These changes are leading to a notable increase in the use of biopsy procedures, as early detection requires tissue confirmation. For example, in January 2025, the Mexican Social Security Institute (IMSS) is improving cancer diagnostic services nationwide through a new agreement with the IMSS-Bienestar Public Agency. The initiative focuses on biomarker studies for breast cancer and childhood leukemia, enabling faster biopsy analysis and improved patient access to care without the need to travel, benefiting both uninsured and IMSS-insured patients. The increased awareness is also encouraging people to seek medical advice earlier, improving the chances of timely diagnosis. As a result, hospitals and diagnostic centers are investing in advanced biopsy tools that offer accurate and minimally invasive sampling. This trend is further reinforced by the fact that public institutions are expanding standardized diagnostic protocols nationwide. These factors are collectively creating a positive outlook for the biopsy device market in Mexico.

Market segmentation of biopsy devices in Mexico:

IMARC Group offers an analysis of key trends in each market segment, along with national and regional forecasts for 2026-2034. Our report has categorized the market based on procedure type, product, guidance technique, application, and end user.

Insights procedure type:

• Surgical biopsy
• Needle biopsy

The report offers a detailed breakdown and analysis of the market based on the type of procedure. This includes surgical biopsy and needle biopsy.

Product Perspectives:

• Biopsy guidance systems
• Needle biopsy guns
• Biopsy needles
• Biopsy forceps
• Others

The report also provides a detailed breakdown and analysis of the market by product. This includes biopsy guide systems, needle biopsy guns, biopsy needles, biopsy forceps, and others.

Perspectives on the guiding technique:

• Ultrasound-guided biopsy
• Stereotactic guided biopsy
• MRI-guided biopsy
• Others

The report also provides a detailed breakdown and analysis of the market based on guidance techniques. This includes ultrasound-guided biopsy, stereotactic-guided biopsy, magnetic resonance-guided biopsy, and others.

Application perspectives:

• Breast biopsy
• Lung biopsy
• Colorectal biopsy
• Biopsia de próstata
• Otros

El informe también ofrece un desglose y un análisis detallados del mercado en función de la aplicación. Esto incluye biopsia de mama, biopsia de pulmón, biopsia colorrectal, biopsia de próstata y otras.

Perspectivas de los usuarios finales:

• Hospitales y clínicas
• Institutos académicos y de investigación
• Otros

El informe también ofrece un desglose y un análisis detallados del mercado en función del usuario final. Se incluyen hospitales y clínicas, institutos académicos y de investigación, y otros.

Perspectivas regionales:

• Norte de México
• México Central
• Sur de México
• Otros

El informe también ha proporcionado un análisis exhaustivo de los principales mercados regionales, que incluyen el norte de México, el centro de México, el sur de México y otros.

Panorama competitivo:

El informe de investigación de mercado también ha proporcionado un análisis exhaustivo del panorama competitivo. El informe incluye análisis de la competencia como la estructura del mercado, el posicionamiento de los actores clave, las principales estrategias ganadoras, el cuadro de mando de la competencia y el cuadrante de evaluación de las empresas. También se ofrecen perfiles detallados de las principales empresas.

Cobertura del mercado de dispositivos de biopsia en México:

Preguntas clave respondidas en este informe:

• ¿Cómo se ha comportado hasta ahora el mercado mexicano de dispositivos de biopsia y cómo se comportará en los próximos años?
• ¿Cuál es el desglose del mercado mexicano de dispositivos de biopsia en función del tipo de procedimiento?
• ¿Cuál es el desglose del mercado mexicano de dispositivos de biopsia por producto?
• ¿Cuál es el desglose del mercado mexicano de dispositivos de biopsia en función de la técnica de orientación?
• What is the breakdown of the Mexican biopsy device market based on application?
• What is the breakdown of the Mexican biopsy device market based on the end user?
• What is the breakdown of the Mexican biopsy device market by region?
• What are the different stages of the biopsy device market value chain in Mexico?
• What are the main driving factors and challenges in the biopsy device sector in Mexico?
• What is the structure of the Mexican biopsy device market and who are its main players?
• What is the level of competition in the Mexican biopsy device market?

Main benefits for stakeholders:

• The IMARC industry report offers a comprehensive quantitative analysis of various market segments, historical and current market trends, market forecasts, and market dynamics for biopsy devices in Mexico from 2020-2034.
• The research report provides the latest information on market drivers, challenges, and opportunities in the biopsy device market in Mexico.
• Porter's Five Forces analysis helps stakeholders assess the impact of new entrants, competitive rivalry, supplier power, buyer power, and the threat of substitution. It helps stakeholders analyze the level of competition in the biopsy device sector in Mexico and its attractiveness.
• The competitive landscape allows stakeholders to understand their competitive environment and provides insight into the current positions of the major market players.